Management of Post‑Infarct Seizures

Acute Seizure Treatment

• Administer intravenous short‑acting benzodiazepines (e.g., lorazepam) for seizures that do not self‑terminate within minutes, and continuously monitor vital signs and neurological status to detect recurrence. International Stroke Guidelines recommend this approach. 1
• Actively search for and correct reversible precipitants, particularly concurrent infections such as pneumonia or urinary‑tract infection, as part of acute management. 1

Indications for Initiating Chronic Antiepileptic Therapy

• Do not start long‑term antiepileptic drugs after a single, self‑limiting seizure occurring within the first 24 hours of stroke onset, because the risk of recurrence is low. International Stroke Guidelines advise observation only. 1
• Begin chronic antiepileptic therapy when a patient experiences two or more seizures, irrespective of the interval from stroke onset. This follows standard seizure‑management protocols. 1

First‑Line Antiepileptic Drug Selection

• Levetiracetam is the preferred first‑line agent because it shows equivalent efficacy to other antiepileptics and a superior safety profile, with fewer episodes of hypotension and a reduced need for endotracheal intubation compared with fosphenytoin. Evidence derives from comparative studies. European Resuscitation Council/European Society of Intensive Care Medicine (2025) guideline endorses this choice. [2][3]
• Sodium valproate is an acceptable alternative first‑line agent, demonstrating comparable effectiveness in suppressing epileptiform activity. European Resuscitation Council/European Society of Intensive Care Medicine (2025) guideline lists it as an option. [2][3]

Agents to Avoid as First‑Line Therapy

• Phenytoin/fosphenytoin should be avoided because they are associated with a markedly higher seizure‑recurrence rate (OR 7.3, 95 % CI 3.7‑14.5) and more adverse events, including hypotension and increased need for intubation, relative to levetiracetam. Evidence comes from observational comparative studies. [2][3]

Prophylactic Antiepileptic Use

• Do not give prophylactic antiepileptic drugs to post‑stroke patients who have not yet had a seizure, regardless of stroke type (ischemic or hemorrhagic). Prophylaxis shows no benefit in preventing seizures or improving outcomes and may cause harm (delayed awakening, prolonged mechanical ventilation, increased ICU stay). Recommendations are based on the European Resuscitation Council/European Society of Intensive Care Medicine (2025) guideline and supported by data from large stroke cohorts. [4][2]3

Electroencephalography (EEG) Monitoring

• Use EEG to diagnose electrographic seizures in patients with clinical convulsions and to monitor treatment response. European Resuscitation Council/European Society of Intensive Care Medicine (2025) guideline specifies these indications. 4
• Apply EEG to detect subclinical seizures in patients with unexplained reduced consciousness. This recommendation is supported by the International Stroke Guidelines. 1

Sedation Considerations

• Propofol is effective in suppressing both clinical convulsions and epileptiform EEG activity in comatose post‑stroke patients. Evidence from comparative studies underpins this practice. 2
• High‑dose sedation combined with conventional antiepileptics can confound neurological examination and delay prognostication, a concern highlighted in stroke‑critical care literature. [2][3]

Management of Myoclonus with Epileptiform Discharges

• Exercise caution with aggressive antiepileptic treatment in patients presenting with generalized myoclonus and epileptiform discharges, as this pattern may represent Lance‑Adams syndrome, which is compatible with favorable neurological recovery. Recommendations are based on expert consensus and observational data. [2][3]
• Consider a wake‑up trial in such patients when EEG shows a benign background several days after the acute event. This approach is endorsed by the European Resuscitation Council/European Society of Intensive Care Medicine (2025) guideline. 4

Management of Post‑Stroke Seizures

Acute Seizure Management

• Administer a short‑acting benzodiazepine (e.g., intravenous lorazepam) for seizures that are not self‑limited. 5
• Actively search for reversible precipitants such as electrolyte disturbances (especially hyponatremia), hypoglycemia, hemorrhagic transformation, and infection. 6
• Continuously monitor vital signs and neurological status to detect recurrent seizure activity. 5

Indications for Long‑Term Antiepileptic Drug (AED) Therapy

Single, Self‑Limited Early Seizure (≤24 h after stroke)

• Do not initiate chronic AED therapy after a solitary early seizure; the recurrence risk is low. 7
• Classify this event as an “early” post‑stroke seizure with a low likelihood of recurrence. 6
• Maintain close inpatient observation for any subsequent seizures. 5

Recurrent Seizures (≥2 episodes)

• Start chronic AED treatment using standard seizure‑management protocols when two or more seizures occur. 7
• Prefer newer‑generation AEDs (e.g., levetiracetam, lamotrigine, gabapentin) over older agents.

Avoidance of Certain AEDs for Chronic Use

• Chronic use of phenytoin or benzodiazepines is discouraged because they may suppress neural plasticity essential for stroke recovery. 8

Prophylactic AED Use

• Routine prophylactic AED administration is not recommended for stroke patients who have not experienced a seizure, regardless of stroke type (ischemic or hemorrhagic). 7
• Potential harms of prophylaxis include:
  
  • Negative impact on neural recovery and behavioral outcomes. 8
  • Significant side‑effect burden without proven benefit. 9
  • Interference with post‑stroke rehabilitation processes. 8

Epidemiology and Risk Assessment

• Early seizures (within 7 days) occur in 2–4 % of ischemic strokes. 9
• The majority of early seizures manifest within the first 24 hours after stroke onset. 8
• Early seizures are typically focal, with or without secondary generalization. 10
• Late seizures/epilepsy are more likely when cortical involvement, hemorrhagic transformation, or pre‑existing dementia are present. 10

Medication Selection and Pitfalls

• Do not reflexively prescribe prophylactic AEDs after hemorrhagic stroke despite higher seizure rates; evidence does not support benefit and may worsen outcomes. 7
• Avoid older AEDs (phenytoin, carbamazepine, phenobarbital) as first‑line agents because of drug‑drug interactions with anticoagulants, adverse cognitive effects, and potential impairment of stroke recovery. 8
• Do not treat a single early seizure with long‑term therapy; recurrence is low and chronic treatment does not improve long‑term outcomes. 11

Monitoring and Follow‑Up

• Obtain electroencephalography (EEG) in patients with unexplained reduced consciousness to identify subclinical seizures. 5
• Re‑evaluate the necessity of continued AED therapy; seizures occurring within two weeks of stroke are usually well‑controlled and may not require indefinite treatment. 9

Management of Post‑Stroke Seizures

Acute Seizure Management

• Administer intravenous lorazepam (a short‑acting benzodiazepine) for seizures that do not self‑terminate within a few minutes; this applies to seizures occurring immediately before or within 24 hours of stroke onset. 12, 13
• Continuously monitor vital signs and neurological status during routine assessments to detect recurrent seizure activity. 12, 13
• Actively search for and correct reversible precipitants—including hyponatremia, hypoglycemia, hemorrhagic transformation, infections (e.g., pneumonia, urinary‑tract infection), and fever > 37.5 °C. 13
• If fever develops, increase temperature‑monitoring frequency and start antipyretic therapy as needed. 13

Decision on Long‑Term Antiepileptic Therapy

Single, Self‑Limited Early Seizure (≤ 24 h)

• Do not initiate chronic antiepileptic drug (AED) therapy after a single seizure occurring within 24 hours of stroke onset; the recurrence risk is low (≈ 20–33 %) and prophylactic treatment does not improve long‑term outcomes. 12, 13
• Continue inpatient observation with routine vital‑sign and neurological monitoring to identify any subsequent seizures. 12, 13

Recurrent Seizures (≥ 2 Episodes)

• Initiate long‑term AED therapy when a patient experiences two or more seizures, irrespective of the interval from stroke onset. 12, 13

Prophylactic Antiepileptic Use

• Do not prescribe prophylactic AEDs to stroke patients who have not experienced a seizure, for both ischemic and hemorrhagic strokes. 12, 13
• Evidence shows no benefit in preventing seizures or improving functional outcomes, and prophylaxis may cause harm to neural recovery. 12, 13

Electroencephalography (EEG) Monitoring

• Obtain an EEG in any patient with unexplained reduced level of consciousness after stroke to detect subclinical seizures. 12, 13
• EEG is especially indicated in neonates and children with stroke and in adults with otherwise unexplained decreased consciousness. 12, 13
• Consider enhanced or prolonged EEG monitoring for patients at higher risk of non‑convulsive seizures. 12, 13